Major conceptual change required to improve lung cancer: See a respiratory physician

European Respiratory Journal

Volumn 21, Issue 4, 2003, Pages 565-566

  Field, J K ^a   Brambilla, C ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Dept de Med Aigue Specialisee   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER STATISTICS; CANCER SURVIVAL; CONSULTATION; EDITORIAL; HIGH RISK PATIENT; HUMAN; LUNG CANCER; MEDICAL PRACTICE; MEDICAL SPECIALIST; PATIENT REFERRAL; PRIORITY JOURNAL; SMOKING CESSATION; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; UNITED KINGDOM;

EID: 0037384290     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00116202     Document Type: Editorial

References (12)

1. Fergusson RJ, Thomson CS, Brewster DH, Brown PH, Milroy R, on behalf of the Scottish Cancer Trials Lung Group and the Scottish Cancer Therapy Network. Lung cancer: the importance of seeing a respiratory physician. Eur Respir J 2003; 21: 606-610.
2. Rintoul RC, Sethi T. The lung cancer paradox: time for action. Thorax 2002; 57: Suppl. 2, II57-II63.
3. Hirsch FR, Franklin WA, Gazdar AF, Bunn PA. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Research 2001; 7: 5-22.
4. Field JK, Brambilla C, Hirsch FR, et al. Molecular biomarkers workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. Lung Cancer 2001; 31: 339-345.
5. Ahrendt SA, Chow JT, Xu LH, et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999; 91: 332-339.
6. Liloglou T, Maloney P, Xinarianos G, et al. Cancer-Specific Genomic Instability (CSGI) in bronchial lavage: a molecular tool for lung cancer detection. Cancer Res 2001; 61: 1624-1628.
7. Henschke CI, McCauley DI, Yankelevitz D, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354: 99-105.
8. Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351: 1242-1245.
9. Ellis SM, Husband JE, Armstrong P, Hansell DM. Computed tomography screening for lung cancer: back to basics. Clin Radiol 2001; 56: 691-699.
10. Thatcher N. New drugs in small cell lung cancer. Suppl Tumori 2002; 4: S26-S27.
11. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8: 816-824.
12. Heighway J, Knapp T, Boyce L, et al. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 2002; 21: 7749-7763.